UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE: RESULTS AT 84 WEEKS FROM THE SELECT-MONOTHERAPY STUDY

被引：3
作者：
Smolen, J. S. [1 ]
Emery, P. [2 ,3 ]
Rigby, W. [4 ]
Tanaka, Y. [5 ]
Vargas, J. Ignacio [6 ]
Damjanov, N. [7 ]
Jain, M. [8 ]
Song, Y. [9 ]
Khan, N. [9 ]
Enejosa, J. J. [9 ]
Cohen, S. B. [10 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Univ Leeds, Leeds, W Yorkshire, England
[3] NIHR Biomed Res Ctr, Leeds, W Yorkshire, England
[4] Dartmouth Coll, Hanover, NH 03755 USA
[5] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[6] Quantum Res, Puerto Varas, Chile
[7] Univ Belgrade, Inst Rheumatol, Sch Med, Belgrade, Serbia
[8] Great Lakes Clin Trials, Chicago, IL USA
[9] AbbVie Inc, N Chicago, IL USA
[10] Metroplex Clin Res Ctr, Dallas, TX USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.961
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0213
引用
收藏
页码：327 / 328
页数：2
相关论文
共 50 条
  • [11] Upadacitinib Monotherapy Improves Patient-Reported Outcomes in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate
    Strand, Vibeke
    Buch, Maya
    Tundia, Namita
    Camp, Heidi S.
    Suboticki, Jessica
    Goldschmidt, Debbie
    Wells, Alvin F.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [12] MONOTHERAPY WITH UPADACITINIB IN MTX-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-EARLY STUDY
    van Vollenhoven, Ronald
    Takeuchi, Tsutomu
    Pangan, Aileen
    Friedman, Alan
    Chen, Su
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo
    Strand, Vibeke
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 376 - 377
  • [13] Comparison of the Effects of Upadacitinib Monotherapy with MTX on Protein Biomarkers in MTX-Naive and MTX-Inadequate Responders in Patients with Active Rheumatoid Arthritis: Results from the SELECT-EARLY and SELECT-MONOTHERAPY Phase 3 Studies
    Sornasse, Thierry
    Camp, Heidi
    Cai, Fang
    Klaff, Justin
    McInnes, Iain
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2563 - 2565
  • [14] Sustainability of Response to Upadacitinib as Monotherapy or in Combination Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Conventional Synthetic DMARDs
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Nash, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [15] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
    Kavanaugh, A.
    Buch, M. H.
    Combe, B.
    Bessette, L.
    Song, I. H.
    Song, Y.
    Suboticki, J.
    Nash, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 323 - 324
  • [16] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Nash, Peter
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 46
  • [17] MONOTHERAPY WITH UPADACITINIB IN MTX-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS
    van Vollenhoven, R.
    Takeuchi, T.
    Pangan, A. L.
    Friedman, A.
    Chen, S.
    Rischmueller, M.
    Blanco, R.
    Xavier, R. M.
    Strand, V.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 12 - 12
  • [18] Monotherapy with Upadacitinib in MTX-naive Patients with Rheumatoid Arthritis: Results at 48 Weeks
    van Vollenhoven, Ronald
    Takeuchi, Tsutomu
    Pangan, Aileen
    Friedman, Alan
    Chen, Su
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo Machado
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [19] Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological DMARDs: Results at 60 weeks from the SELECT-BEYOND Study
    Andrea, Rubbert-Roth
    Genovese, M. C.
    Combe, B.
    Hall, S.
    Sheng, Zhong
    Sebastian, Meerwein
    Roy, Fleischmann
    SWISS MEDICAL WEEKLY, 2019, : 7S - 7S
  • [20] Upadacitinib As Monotherapy: A Phase 3 Randomized Controlled Double-Blind Study in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
    Smolen, Josef S.
    Cohen, Stanley
    Emery, Paul
    Rigby, William F. C.
    Tanaka, Yoshiya
    Zhang, Ying
    Friedman, Alan
    Othman, Ahmed A.
    Camp, Heidi S.
    Pangan, Aileen L.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345